Kazia Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KZIA and other ETFs, options, and stocks.

About KZIA

Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. It focuses on its Paxalisib program, which is designed to treat brain cancer.

CEO

John E. Friend

CEOJohn E. Friend

Employees

—

Employees—

Headquarters

Sydney, New South Wales (NSW)

HeadquartersSydney, New South Wales (NSW)

Founded

1994

Founded1994

Employees

—

Employees—

KZIA Key Statistics

Market cap

75.74M

Market cap75.74M

Price-Earnings ratio

-0.51

Price-Earnings ratio-0.51

Dividend yield

—

Dividend yield—

Average volume

251.83K

Average volume251.83K

High today

$7.02

High today$7.02

Low today

$6.13

Low today$6.13

Open price

$6.28

Open price$6.28

Volume

305.84K

Volume305.84K

52 Week high

$17.40

52 Week high$17.40

52 Week low

$2.86

52 Week low$2.86

Kazia Therapeutics

Why Robinhood?

Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. It focuses on its Paxalisib program, which is designed to treat brain cancer. Show more

KZIA Key Statistics

Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. It focuses on its Paxalisib program, which is designed to treat brain cancer.